Spyre Therapeutics, Inc.
SYRE • NASDAQ
Spyre Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Cameron Turtle, with a market cap of $6.1B.
Market Cap$6.1B
Employees30.0
CEOCameron Turtle
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 14, 2026 · In 3 weeksAfter Market Close · Q1 2026
Financials
Spyre Therapeutics, Inc. FAQ
Common questions about Spyre Therapeutics, Inc.
Spyre Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 14, 2026 after market close. Analysts estimate revenue of $70.9M.
Spyre Therapeutics, Inc. has approximately 30 employees.